Cormorant Asset Management

Cormorant Asset Management as of Dec. 31, 2014

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 70 positions in its portfolio as reported in the December 2014 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Receptos 12.1 $79M 642k 122.51
Puma Biotechnology (PBYI) 6.4 $42M 220k 189.27
Celgene Corporation 5.2 $34M 300k 111.86
Ovascience 5.1 $33M 747k 44.22
Alkermes (ALKS) 4.1 $26M 450k 58.56
Neurocrine Biosciences (NBIX) 3.4 $22M 1.0M 22.34
Dyax 3.2 $21M 1.5M 14.06
Ardelyx (ARDX) 3.1 $20M 1.1M 18.89
Quotient 3.0 $20M 1.1M 18.00
Regulus Therapeutics 2.7 $18M 1.1M 16.04
Sorrento Therapeutics (SRNE) 2.7 $18M 1.8M 10.07
Portola Pharmaceuticals 2.6 $17M 600k 28.32
Chimerix (CMRX) 2.5 $16M 400k 40.26
Bristol Myers Squibb (BMY) 2.3 $15M 250k 59.03
Kite Pharma 2.3 $15M 255k 57.67
Omeros Corporation (OMER) 2.2 $14M 582k 24.78
Karyopharm Therapeutics (KPTI) 2.2 $14M 385k 37.43
Keryx Biopharmaceuticals 2.2 $14M 1.0M 14.15
Tesaro 1.7 $11M 300k 37.19
Dex (DXCM) 1.7 $11M 200k 55.05
BioCryst Pharmaceuticals (BCRX) 1.5 $9.7M 800k 12.16
Acceleron Pharma 1.5 $9.7M 250k 38.96
Synageva Biopharma 1.4 $9.3M 100k 92.79
Novavax 1.4 $8.9M 1.5M 5.93
Sangamo Biosciences (SGMO) 1.2 $7.6M 500k 15.21
Alder Biopharmaceuticals 1.1 $7.3M 250k 29.09
Heron Therapeutics (HRTX) 1.1 $7.0M 700k 10.06
Nektar Therapeutics (NKTR) 1.1 $7.0M 450k 15.50
Acelrx Pharmaceuticals 1.0 $6.7M 1.0M 6.73
Advaxis 1.0 $6.7M 840k 8.01
Aptose Biosciences 1.0 $6.4M 1.1M 5.91
Eagle Pharmaceuticals (EGRX) 1.0 $6.2M 400k 15.50
China Biologic Products 0.9 $6.1M 90k 67.23
Ultragenyx Pharmaceutical (RARE) 0.8 $5.3M 120k 43.88
Auspex Pharmaceuticals 0.8 $5.2M 100k 52.48
Array BioPharma 0.7 $4.7M 1.0M 4.73
Versartis 0.7 $4.5M 200k 22.45
Immune Design 0.7 $4.3M 140k 30.78
Nanostring Technologies (NSTGQ) 0.6 $4.2M 300k 13.93
Rockwell Medical Technologies 0.6 $4.1M 400k 10.28
Bristol-myers Squibb 0.6 $3.7M 5.0k 740.00
Coherus Biosciences (CHRS) 0.6 $3.6M 222k 16.32
Dermira 0.6 $3.6M 200k 18.11
Avalanche Biotechnologies In 0.5 $3.5M 65k 54.00
Lipocine 0.5 $3.5M 667k 5.26
Glycomimetics (GLYC) 0.5 $3.4M 472k 7.20
Dicerna Pharmaceuticals 0.5 $3.3M 200k 16.47
Agenus 0.5 $3.2M 800k 3.97
Forward Pharma A/s 0.5 $3.1M 150k 20.83
Genvec 0.4 $2.8M 1.3M 2.08
Cerulean Pharma 0.4 $2.8M 450k 6.22
Kindred Biosciences 0.4 $2.6M 350k 7.45
Aquinox Pharmaceuticals 0.3 $2.3M 300k 7.50
Recro Pharma 0.3 $2.0M 700k 2.86
Cellectar Biosciences 0.2 $1.6M 530k 3.09
Celsus Therapeutics Plc sponsored adr ne 0.2 $1.4M 300k 4.80
Akebia Therapeutics (AKBA) 0.2 $1.4M 118k 11.64
Bellicum Pharma 0.2 $1.4M 60k 23.03
Applied Genetic Technol Corp C 0.2 $1.3M 61k 21.02
Galectin Therapeutics (GALT) 0.2 $1.1M 312k 3.47
Minerva Neurosciences 0.2 $1.1M 175k 6.02
Veracyte (VCYT) 0.1 $968k 100k 9.66
Scynexis 0.1 $998k 100k 9.98
Curis 0.1 $900k 600k 1.50
Agile Therapeutics 0.1 $921k 150k 6.14
Ptc Therapeutics I (PTCT) 0.1 $518k 10k 51.80
Epirus Biopharmaceuticals In 0.1 $425k 75k 5.67
Cellectar Biosciences Inc *w exp 08/19/201 0.1 $424k 530k 0.80
Nevro (NVRO) 0.1 $387k 10k 38.70
Sage Therapeutics (SAGE) 0.0 $37k 1.0k 37.00